Conduction system pacing following septal myectomy: Insights into site of conduction block

Rujie Zheng1,2, Yingxue Dong3, Shengjie Wu1,2

  • 1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Left bundle branch area pacing (LBBAP) is a feasible strategy for patients with hypertrophic cardiomyopathy (HCM) and conduction block after septal myectomy. His bundle pacing (HBP) was less successful in these patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Surgery

Background:

  • Septal myectomy for obstructive hypertrophic cardiomyopathy (HCM) can lead to conduction block.
  • The electrophysiological characteristics of this conduction block are not well understood.

Purpose of the Study:

  • To assess the feasibility and safety of His bundle pacing (HBP) and left bundle branch area pacing (LBBAP).
  • To evaluate these pacing strategies in patients with septal myectomy-associated conduction block.

Main Methods:

  • Included patients with HCM and pacing indications post-myectomy.
  • Performed electrophysiological mapping to identify the site of block.
  • Recorded success rates and pacing characteristics of HBP and LBBAP, along with echocardiographic data and complications.

Main Results:

  • Ten patients with atrioventricular block or left bundle branch block post-myectomy were studied.
  • The block was infra-Hisian in nine patients with atrioventricular block.
  • HBP failed in most cases, while LBBAP was successful in nine out of ten patients, significantly narrowing QRS duration.

Conclusions:

  • The conduction block post-myectomy is often infra-Hisian and not amenable to HBP.
  • LBBAP presents a more feasible and physiological pacing strategy for these specific patients.
Abstract

Related Concept Videos

Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
10.5K
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
142
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.2K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
144
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
48
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
77